Corin receives FDA 510(k) clearance of Icona femoral stem
Click Here to Manage Email Alerts
Key takeaways:
- Corin received FDA clearance of its Icona femoral stem for direct anterior total hip arthroplasty.
- Icona is a collared, metaphyseal-filling, triple-taper femoral stem.
Corin has received FDA 510(k) clearance of its Icona femoral stem for direct anterior total hip arthroplasty with design considerations for use in the ASC setting, according to a press release.
The Icona femoral stem, which was designed using data from the CorinRegistry, is a collared, metaphyseal-filling, triple-taper stem for THA procedures, according to the release.
“With design features tailored to the direct anterior approach and streamlined instrumentation for ASCs, Icona reflects the implementation of real-world data in innovation,” Cynthia Ansari, chief commercial officer at Corin USA, said in the release.
According to the release, Icona is available through a limited market release in the United States.